Alpha-2 adrenergic receptor agonists to reduce mortality and improve outcomes in viral respiratory syndromes
AssigneeRush University Medical Center
InventorsJohn L. HAMILTON, Markus A. WIMMER
Life of this patent
Estimating the term…
Abstract
Methods for treating viral respiratory syndromes are disclosed. In some aspects, the methods include administering a non-sedative therapeutically effective amount of an α-2 adrenergic receptor (AR) agonist to the subject. In some aspects, the methods include administering a therapeutically effective amount of an α-2 adrenergic receptor (AR) agonist and a therapeutically effective amount of an α-1 adrenergic receptor (AR) antagonist to the subject.
Claims18
A method of treating a viral respiratory syndrome in a subject, the method comprising:
- administering a non-sedative therapeutically effective amount of an α-2 adrenergic receptor (AR) agonist to the subject.
A method of treating a viral respiratory syndrome in a subject, the method comprising:
- administering a therapeutically effective amount of an α-2 adrenergic receptor (AR) agonist and a therapeutically effective amount of an α-1 adrenergic receptor (AR) antagonist to the subject.
Dependencies are inferred from the claim text.